Arpa Garay, Chief Commercial Officer at Moderna, Inc. (MRNA), sold 4,580 shares at $125.75 ($576K) on 2023-06-06, disclosed to the SEC on 2023-06-07.
Scheduled sale ($576k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.75 | 2,290 | $288K | 50.0% |
| 2 | $125.75 | 2,290 | $288K | 50.0% |
| Total | $125.75 avg | 4,580 | $576K | 100% |
| Filing → |